IVF After a Failed Cycle: How to Recalculate Your Protocol, Clinic, and Total Cost Before Spending Another $25K
IVF After a Failed Cycle: How to Recalculate Your Protocol, Clinic, and Total Cost Before Spending Another $25K
You just got the call. The transfer didn't work, or there were no euploid embryos to transfer, or the retrieval only yielded one blastocyst and it didn't survive the thaw. Whatever the specific shape of this particular failure, the math in your head is already running: We've spent $25,000. Do we do this again? Do we do it differently? Do we do it somewhere else?
That question — not "should we keep trying" but "are we doing this the right way at the right place" — is the one most clinics are not incentivized to help you answer rigorously. This post will.
What Your Failed Cycle Actually Gave You (Besides a Bill)
A failed IVF cycle is genuinely devastating. It's also, clinically speaking, an enormous data set that you didn't have before you started. Before you authorize another retrieval, pull every number from your chart:
- Peak estradiol (E2) on trigger day — was it over 3,000 pg/mL? Under 1,500?
- Number of follicles retrieved vs. mature (MII) eggs — a low maturity rate (under 70%) may indicate a trigger timing or protocol issue
- Fertilization rate — normal is 60–80% via ICSI; if yours was under 50%, that's a conversation starter
- Blastocyst development rate — of fertilized eggs, how many made it to day 5/6? Under 30% is below average
- PGT-A results (if you tested) — what percentage were euploid (chromosomally normal)? At 35, expect roughly 50–60% euploidy; at 40, expect 20–30%
- Endometrial lining on transfer day — was it trilaminar and at least 7mm?
This is the data your next protocol decision should rest on. If your clinic's response to a failed cycle is "let's do the same thing again," that deserves a direct challenge.
Protocol Selection: The Decision Nobody Explains Clearly
There are three main stimulation protocols in common use, and they have meaningfully different costs, timelines, and applications:
| Protocol | Typical Duration | Medication Cost Range | Best For |
|---|---|---|---|
| Antagonist (GnRH antagonist) | 10–12 days stim | $3,500–$6,000 | Most patients; lower OHSS risk |
| Long Lupron (agonist down-reg.) | 3–4 weeks total | $4,000–$7,500 | Endometriosis; some DOR cases |
| Mini/Minimal stim IVF | 8–10 days stim | $1,200–$2,500 | Low ovarian reserve; multiple cycles |
| Natural cycle IVF | Monitoring only | $500–$1,000 | Very low reserve; patient preference |
The protocol your clinic selects has a direct line to your medication bill — which, as covered in the IVF total cost breakdown for 2026, is the single biggest source of sticker-shock beyond the base retrieval fee.
If your first cycle used a standard antagonist protocol and you had a poor response (under 4 mature eggs), your doctor may recommend switching to a "microdose Lupron flare" or an "estrogen priming" protocol — either of which changes your medication timeline and bill. If you had a hyper-response (OHSS risk, over 20 follicles), a freeze-all cycle with a lower-dose protocol protects you and changes your FET timeline.
The cost implication is real: Switching from antagonist to a long Lupron protocol can add $1,000–$3,500 in additional medications and 2–3 additional weeks of monitoring visits (each $200–$600 depending on your clinic's monitoring fee structure).
Running the Cumulative Probability Math — For Your Specific Age
This is where most patients understandably get lost. Here's a simplified but honest framework.
Using SART's published live birth rate data (2021 reporting cycle, the most recent complete data set), here are approximate per-transfer live birth rates by age using own eggs:
| Age at Retrieval | Per-Transfer LBR (own eggs) | Euploidy Rate (approx.) |
|---|---|---|
| Under 35 | 50–55% | 55–65% |
| 35–37 | 40–45% | 45–55% |
| 38–40 | 28–35% | 30–40% |
| 41–42 | 18–22% | 20–28% |
| Over 42 | 8–12% | 10–18% |
The cumulative probability across multiple cycles compounds these numbers. At 38, with a 30% per-transfer success rate, your cumulative probability of a live birth across 3 complete cycles is approximately:
- After 1 cycle: 30%
- After 2 cycles: 1 - (0.70 × 0.70) = 51%
- After 3 cycles: 1 - (0.70 × 0.70 × 0.70) = 66%
That third cycle adds roughly 15 percentage points of cumulative probability — but it costs another $22,000–$30,000 out of pocket if you're uninsured or underinsured. Whether that math makes sense for your situation depends on factors no clinic quote sheet will spell out for you.
Feralyx runs this modeling with your actual age, diagnosis, and clinic's SART-reported transfer rates — not generic population averages.
Is Your Clinic's Success Rate Actually Yours?
Before you default to cycling again at the same clinic, spend 20 minutes with SART data. The critical question isn't "what's this clinic's headline live birth rate?" — it's "what's their rate for patients with my diagnosis, my age, and my AMH range?"
Clinics can and do influence their own statistics by:
- Canceling poor-response cycles before retrieval (cycle cancellation rates aren't prominently displayed)
- Declining patients with very low prognosis (good for their numbers, bad for you if you got in anyway)
- Transferring more embryos to inflate live birth rates per patient vs. per transfer
The guide to reading SART data by age and diagnosis walks through how to do this comparison in detail. The short version: look at live births per intended egg retrieval, not per transfer. That denominator includes canceled cycles and failed retrievals — and it tells you a very different story.
Clinic-to-clinic variation for the same patient profile can easily be 15–20 percentage points in live birth rate. At $25,000 per cycle, choosing the wrong clinic by not reading the data is among the most expensive mistakes in this process.
The 2026 Financial Pressure Patients Aren't Accounting For
Here's the part that isn't in your fertility clinic's financial counseling packet.
Two converging forces are making IVF financing harder in 2026 than it was two years ago:
1. Medicaid coverage erosion. A 2025 Urban Institute and Robert Wood Johnson Foundation study estimated that between 5 million and 10 million people could be disenrolled from Medicaid under proposed federal work requirements and more frequent eligibility re-checks. For fertility patients in states with limited private insurance mandates, Medicaid has sometimes been the only pathway to any coverage for monitoring, bloodwork, or early diagnostic steps. If you're counting on that to offset any portion of your next cycle, model the scenario where that coverage disappears mid-treatment. The full picture of IVF insurance coverage changes heading into 2026 is worth reading before you finalize your financing plan.
2. Student loan payment increases. The SAVE income-driven repayment plan — which had temporarily reduced monthly payments to $0 for millions of borrowers with lower incomes — is being wound down, with borrowers given a 90-day window starting July 1, 2025 to switch to a different plan. For fertility patients who had been banking the difference between SAVE payments and a standard plan to fund treatment, this is a direct hit to the IVF savings runway. If your monthly loan payment is about to jump $300–$600, that changes how many months you have before your embryo storage fees become a competing pressure, or how quickly you need to start a funded cycle vs. waiting.
Some patients are attempting to bridge these gaps with credit card rewards or statement credits on medical spend — and while that can offset $200–$500 at the margins, it does not move the needle on a $25,000 cycle. Treat it as a rounding error, not a strategy.
The Decision Framework: Same Clinic, New Protocol, or Clinic Switch?
Here's a practical triage based on what your cycle data showed:
Stay at your clinic, change protocol if:
- Retrieval count was low but you had good fertilization and embryo quality
- Your doctor can point to a specific protocol adjustment with a clinical rationale (not just "let's try more medication")
- Clinic's SART data for your age bracket is within 5 percentage points of the regional average
Get a second opinion consult before next cycle if:
- You had unexplained poor embryo quality with no diagnosis
- Your clinic has a significantly below-average live birth rate for your age group in SART data
- You were pressured toward a specific protocol or add-on (endometrial scratching, EMMA/ALICE, etc.) without supporting evidence for your case
Seriously model a clinic switch if:
- Cost differential between clinics in your region is more than $4,000 per cycle AND the higher-cost clinic has demonstrably better outcomes for your age/diagnosis
- You're moving from a one-cycle-at-a-time approach to evaluating a shared-risk or refund program, which some clinics offer and others don't
- Your clinic doesn't routinely discuss cumulative probability with you — only per-cycle numbers
Before You Book the Next Retrieval
The most important thing you can do before your next cycle isn't finding a new protocol or a new clinic. It's building the comparison with your actual numbers.
What's the cumulative probability of live birth across 2–3 cycles at your current clinic versus the two alternatives in your region? What does total out-of-pocket look like across those scenarios, including meds, monitoring, PGT, storage, and the FET you'll almost certainly need? And how does that math change if your insurance coverage shifts in 2026?
These aren't questions you should be answering on a legal pad at 11pm. They're exactly what Feralyx is built to model — so you can walk into your next consultation with the data, not just the hope.
Sources
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members — KFF Reproductive Health
- 10M could lose Medicaid due to work requirements, more frequent eligibility checks: study — Healthcare Dive
- End Finally Comes for SAVE Student Loan Plan: Millions Given Deadline to Switch — NerdWallet Health
- Miraval Berkshires Resort: A Relaxing and Renewing Retreat — NerdWallet Health
- What Are Credit Card Statement Credit Benefits Really Worth? — NerdWallet Health